SEC Form 5 · accession 0001477932-17-003732
Innovation Pharmaceuticals Inc. · IPIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Leo Ehrlich
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Jun 30, 2017
Accepted (ET)
Aug 8, 2017 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001355250
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Jul 25, 2016 | G | 50,000 | $0.00 | D | 8,535,002 | D | |
| Class A Common Stock | Dec 28, 2016 | G | 100,000 | $0.00 | D | 8,435,002 | D | |
| Class A Common Stock | Dec 28, 2016 | G | 100,000 | $0.00 | D | 8,335,002 | D | |
| Class A Common Stock | Dec 28, 2016 | G | 1,000,000 | $0.00 | D | 7,335,002 | D | |
| Class A Common Stock | Dec 28, 2016 | G | 1,000,000 | $0.00 | A | 1,000,000 | I | By son |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On July 25, 2016, the reporting person gifted 50,000 shares to Boca Raton Synagogue.
- F2On December 28, 2016, the reporting person gifted 100,000 shares to Boca Raton Synagogue.
- F3On December 28, 2016, the reporting person gifted 100,000 shares to Yeshiva Tiferes Torah of Boca Raton.
- F4On December 28, 2016, the reporting person gifted 1,000,000 shares to his son.
- F5This transaction involved a gift of securities by the reporting person to his son. The reporting person may be deemed to have an indirect pecuniary interest in the shares owned by his son. The reporting person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or any other purpose.